About HilleVax, Inc. 
HilleVax, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 26 Schemes (14.29%)
Foreign Institutions
Held by 42 Foreign Institutions (23.6%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
Pharmaceuticals & Biotechnology
USD 105 Million ()
NA (Loss Making)
NA
0.00%
-1.05
-30.09%
0.71






